武漢理工大學(xué)

武漢理工大學(xué)材料科學(xué)與工程學(xué)院研究生導(dǎo)師韓穎超介紹如下：

韓穎超
基本情況:
出生年月:1977.4
學(xué)位:博士
職稱:副研究員
工作院系:新材料研究所/生物材料與工程研究中心

教育經(jīng)歷(從大學(xué)開(kāi)始)

1996年9月～2000年7月,武漢理工大學(xué),獲工學(xué)學(xué)士學(xué)位;
2000年9月～2002年7月,武漢理工大學(xué),獲工學(xué)碩士學(xué)位;
2005年3月～2007年12月,武漢理工大學(xué),獲工學(xué)博士學(xué)位;

工作經(jīng)歷

2002年7月～2004年10月,武漢理工大學(xué)生物材料與工程研究中心,研究實(shí)習(xí)員;
2004年11月～2009年10月,武漢理工大學(xué)生物材料與工程研究中心,助理研究員;
2010年6月～2012年6月,美國(guó)內(nèi)布拉斯加大學(xué)醫(yī)學(xué)中心博士后。
2009年11月～至今, 武漢理工大學(xué)生物材料與工程研究中心,副研究員;

研究領(lǐng)域(不多于3個(gè))

納米生物材料,藥物可控釋放,納米醫(yī)學(xué)

科研項(xiàng)目(不多于5項(xiàng))

國(guó)家自然科學(xué)基金:稀土摻雜羥基磷灰石納米粒子熒光探針的制備及應(yīng)用研究
中央高�；�本科研業(yè)務(wù)費(fèi)專項(xiàng)資金:稀土元素共摻雜羥基磷灰石納米粒子及熒光增強(qiáng)效應(yīng)研究
國(guó)家重點(diǎn)實(shí)驗(yàn)室開(kāi)放基金：稀土摻雜羥基磷灰石納米粒子的可控制備與體內(nèi)分布代謝規(guī)律

代表性論文及著作(不多于10項(xiàng))

[1]A. Schulz, S. Jaksch, R. Schubel, E. Wegener, Z.Y. Di, Y.C. Han, A. Meister, J. Kressler, A.V. Kabanov, R. Luxenhofer, C.M. Papadakis, R. Jordan. Drug-Induced Morphology Switch in Drug Delivery Systems Based on Poly(2-oxazoline)s . ACS NANO, 2014, 8(3): 2686-2696.
[2]Y.C. Han, X.Y. Wang, H.L. Dai, S.P. Li. Synthesis and luminescence of Eu3+ doped hydroxyapatite nanocrystallines: Effects of calcinations and Eu3+ content. Journal of Luminescence, 2013, 135:281-287
[3]Y.C. Han, X.Y. Wang, H.L. Dai, S.P. Li. Nanosize and Surface Charge Effects of Hydroxyapatite Nanoparticles on Red Blood Cell Suspensions. ACS Appl. Mater. Interfaces, 2012, 4 (9):4616–4622.
[4]Y.C. Han, Z.J. He, A. Schulz, T.K. Bronich, R. Jordan, R. Luxenhofer, A.V. Kabanov. Synergistic Combinations of Multiple Chemotherapeutic Agents in High Capacity Poly(2-oxazoline) Micelles. Mol. Pharmaceutics, 2012, 9 (8): 2302–2313.
[5]R. Luxenhofer, Y.C. Han, A. Schulz, J. Tong, Z.J. He, A.V. Kabanov, R. Jordan. Poly(2-oxazoline)s as polymer therapeutics. Macromol Rapid Commun. 2012, 33(19):1613-1631.
[6]Y.C. Han, X.Y. Wang, S.P. Li. Biocompatible Europium doped Hydroxyapatite Nanoparticles as a Biological Fluorescent Probe. Current Nanoscience, 2010, 6(2): 178-183.
[7]Y.C. Han, X.Y. Wang, S.P. Li. A simple route to prepare stable hydroxyapatite nanoparticles suspension. Journal of Nanoparticle Research, 2009, 11(5): 1235-1240.
[8]I. Bauer, S.P. Li, Y.C. Han, L. Yuan, M.Z. Yin. Internalization of hydroxyapatite nanoparticles in liver cancer cells. Journal of Materials Science: Materials in Medicine, 2008, 19(3): 1091-1095.
[9]美國(guó)發(fā)明專利: US7989532 B2. RGD polypeptide grafted poly (glycolic acid-L-lysine-L-lactic acid)/β-tricalcium phosphate composite material and preparation method thereof. Li Shipu, Han Yingchao, Yan Yuhua, Wan Tao, Wang Xinyu, Yuan Lin, Dai Honglian, Yan Qiongjiao.  2011.8授權(quán)
[10]歐洲發(fā)明專利: EP2039377 B1. RGD polypeptide grafted poly (glycolic acid-L-lysine-L-lactic acid)/β-tricalcium phosphate composite material and preparation method thereof. Li Shipu, Han Yingchao, Yan Yuhua, Wan Tao, Wang Xinyu, Yuan Lin, Dai Honglian, Yan Qiongjiao. 2012. 9授權(quán)
聯(lián)系方式:
電話:18986218516, 15927360395
E-mail:hanyingchao@whut.edu.cn
工作地址(實(shí)驗(yàn)室):武漢理工大學(xué)西院逸夫樓7樓
 
 
 
 
 
Name:   Yingchao Han
Personal information
Date of birth: April, 1977
Education: Doctor Degree of Engineering, Wuhan University of Technology
Major: Biomedical materials
Position: Associate Researcher
Work place: Institute of New Materials/Biomedical Materials and Engineering Center
Education
1996.9-2000.7, Bachelor Degree in Materials Science, Wuhan University of Technology, China
2000-2002, Master Degree in Materials Science, Wuhan University of Technology, China
2005-2007, Doctor Degree in Biomedical Materials, Wuhan University of Technology, China
Positions and Employment
2002.7-2004.10      Researcher Assistant, Wuhan University of Technology, P.R. China
2004.11-2009.10    Assistant Researcher, Wuhan University of Technology, P.R. China
2010.6-2012.6      Postdoctoral Research Fellow, University of Nebraska Medical Center
2009.11-present     Associate Researcher, Wuhan University of Technology, P.R. China
Research Area and Interests:
1. Bioceramic and biomedical inorganic nanomaterials
 1.1 Synthesis of hydroxyapatite (HAP) powders and fabrication of HAP bioceramics;
 1.2 Adsorption properties of HAP nanoparticles to some biomolecules (such as serum albumin, heparin and salic acid) and the interaction of HAP nanoparticles cancer cells;
 1.3 Preparation and application of rare earth doped HAP nanoparticles with fluorescent property in cell labelling.
 1.4 Applications of HAP nanoparticles as drug or gene carriers
2. Drug delivery nano-carrier system and drug formulation
 2.1 Preparation technology of anti-cancer drug loading amphiphilic block micelles formulation;
 2.2 Synergistic effects study between multiple anti-cancer drugs
Project:
National Natural Science Foundation of China: Preparation and application of rare earth doped hydroxyapatite nanoparticles fluorescence probe
Fundamental Research Funds for the Central Universities: Study on rare earth elements co-doped hydroxyapatite nanoparticles and fluorescence enhancing effect
Opening fund of State Key Laboratory: Controlled preparation of rare earth doped hydroxyapatite nanoparticle and in vivo biodistribution and metabolism
Selected paper and patent (no more than 10)
[1] A. Schulz, S. Jaksch, R. Schubel, E. Wegener, Z.Y. Di, Y.C. Han, A. Meister, J. Kressler, A.V. Kabanov, R. Luxenhofer, C.M. Papadakis, R. Jordan. Drug-Induced Morphology Switch in Drug Delivery Systems Based on Poly(2-oxazoline)s . ACS NANO, 2014, 8(3): 2686-2696.
[2] Y.C. Han, X.Y. Wang, H.L. Dai, S.P. Li. Synthesis and luminescence of Eu3+ doped hydroxyapatite nanocrystallines: Effects of calcinations and Eu3+ content. Journal of Luminescence, 2013, 135:281-287
[3] Y.C. Han, X.Y. Wang, H.L. Dai, S.P. Li. Nanosize and Surface Charge Effects of Hydroxyapatite Nanoparticles on Red Blood Cell Suspensions. ACS Appl. Mater. Interfaces, 2012, 4 (9):4616–4622.
[4] Y.C. Han, Z.J. He, A. Schulz, T.K. Bronich, R. Jordan, R. Luxenhofer, A.V. Kabanov. Synergistic Combinations of Multiple Chemotherapeutic Agents in High Capacity Poly(2-oxazoline) Micelles. Mol. Pharmaceutics, 2012, 9 (8): 2302–2313.
[5] R. Luxenhofer, Y.C. Han, A. Schulz, J. Tong, Z.J. He, A.V. Kabanov, R. Jordan. Poly(2-oxazoline)s as polymer therapeutics. Macromol Rapid Commun. 2012, 33(19):1613-1631.
[6] Y.C. Han, X.Y. Wang, S.P. Li. Biocompatible Europium doped Hydroxyapatite Nanoparticles as a Biological Fluorescent Probe. Current Nanoscience, 2010, 6(2): 178-183.
[7] Y.C. Han, X.Y. Wang, S.P. Li. A simple route to prepare stable hydroxyapatite nanoparticles suspension. Journal of Nanoparticle Research, 2009, 11(5): 1235-1240.
[8] I. Bauer, S.P. Li, Y.C. Han, L. Yuan, M.Z. Yin. Internalization of hydroxyapatite nanoparticles in liver cancer cells. Journal of Materials Science: Materials in Medicine, 2008, 19(3): 1091-1095.
[9] United States Patent: US7989532 B2. RGD polypeptide grafted poly (glycolic acid-L-lysine-L-lactic acid)/β-tricalcium phosphate composite material and preparation method thereof. Li Shipu, Han Yingchao, Yan Yuhua, Wan Tao, Wang Xinyu, Yuan Lin, Dai Honglian, Yan Qiongjiao.  2011.8 issued.
[10] European Patent: EP2039377 B1. RGD polypeptide grafted poly (glycolic acid-L-lysine-L-lactic acid)/β-tricalcium phosphate composite material and preparation method thereof. Li Shipu, Han Yingchao, Yan Yuhua, Wan Tao, Wang Xinyu, Yuan Lin, Dai Honglian, Yan Qiongjiao. 2012. 9 issued.
Contact information:
Tel:18986218516, 15927360395
E-mail:hanyingchao@whut.edu.cn
Address (Lab): 7th floor, YIFU Building, Wuhan University of Technology